Bryan, Garnier & Co's News Galapagos: What will be Galapagos’s commercial strategy for its proprietary IPF compound? BUY, Fair Value EUR61 (+5%) News published on September Tuesday 22, 2015 Share on For more information, please contact marketing@bryangarnier.com